Physician profile
Daniel L Harris
NPI 1942332242
$930.91
in general payments reported to CMS, 2019-2025
11 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.20 · 2020: $60.74 · 2021: $90.96 · 2022: $200 · 2023: $68.01 · 2024: $121 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $183.11 | 2022-2024 | Senza |
| Globus Medical, INC. | $176.53 | 2025 | Senza |
| Vertos Medical, INC. | $162.31 | 2021-2024 | Mild Device Kit |
| Boston Scientific Corporation | $106.26 | 2019-2025 | General - Pain Management |
| Biotronik Nro, INC. | $72.32 | 2025 | Prospera |
| Nalu Medical, INC. | $68.75 | 2022-2025 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $67.42 | 2019-2020 | |
| Redhill Biopharma INC. | $39.19 | 2021 | |
| Orexo US, INC. | $24.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.55 | 2022 | |
| Daiichi Sankyo INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.